Abstract: Objective: To develop a whole-process blood glucose management protocol for patients undergoing Continuous Subcutaneous Insulin Infusion (CSII) therapy in non-endocrinology departments based on in-hospital grid management and to explore its effects, so as to provide a reference for improving patients' blood glucose management. Methods: A quasi-experimental study design was adopted. The convenience sampling was used to recruit 200 patients receiving CSII therapy in non-endocrinology departments from a tertiary grade B hospital in Dongying. A total of 100 patients treated with CSII from January to June 2024 were assigned to the control group, receiving routine blood glucose management; another 100 patients treated with CSII from July to December 2024 were assigned to the intervention group, receiving whole-process blood glucose management based on in-hospital grid management. The average time to blood glucose control during CSII therapy, incidence of hypoglycemia, the Glycated Hemoglobin A1c (HbA1c) control rate 3 months after discharge, the outpatient revisit rate, and the patient satisfaction were compared between the two groups. Results: The average time to blood glucose control during CSII treatment for patients in the intervention group was 3.62±0.96 days, while that of the control group was 4.74±1.26 days, the incidence of in-hospital and out-of-hospital hypoglycemia for patients in the intervention group were both lower than those of the control group, the HbA1c control rate 3 months after discharge, the outpatient revisit rate, and the patient satisfaction for patients in the intervention group were all higher than those of the control group, all differences were statistically significant (P<0.05). Conclusion: Whole-process blood glucose management based on in-hospital grid management can improve blood glucose control indicators, reduce the risk of hypoglycemia, and increase the outpatient revisit rate and patient satisfaction among patients undergoing CSII therapy in non-endocrinology departments.

Key words: Continuous Subcutaneous Insulin Infusion; grid management; whole-process management; blood glucose management; model